Alembic Pharma Joint Venture gets USFDA nod for antifungal topical solution
NEW DELHI: Drug firm Alembic Pharmaceuticals on Thursday said its joint venture firm Aleor Dermaceuticals has received final approval from the US health regulator for anti-fungal Tavaborole Topical Solution. Tavaborole Topical solution is an antifungal indicated for the treatment of onychomycosis of the toenails. Aleor Dermaceuticals has received final approval from the US Food and […]